PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer
D.J. Hughes(St Thomas' Hospital), Gary Cook(Guy's Hospital), Scott Edmonds, Damion Bailey(Guy's and St Thomas' NHS Foundation Trust), Spyridon Gennatas(Guy's and St Thomas' NHS Foundation Trust), Eleni Karapanagiotou(King's College London), James Spicer(King's College London), Gitasha Chand(Shanghai First People's Hospital), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Hong Hoi Ting(Sanskriti Samvardhan Mandal), Vicky Goh(King's College London), Alexandros Georgiou(King's College London), Ronan Tegala(Guy's and St Thomas' NHS Foundation Trust), Jessica Johnson(University of North Carolina at Chapel Hill), Emma McLean, Susan Ndagire(Guy's and St Thomas' NHS Foundation Trust), Amelia E.B. Moore(King's College London), Sharmistha Ghosh(Guy's and St Thomas' NHS Foundation Trust), Thubeena Manickavasagar(King's College London), Kathryn Adamson(Guy's and St Thomas' NHS Foundation Trust), Levente K. Meszaros
Cited by 4
Related Papers
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k
Regulation of tradeoffs between plant defenses against pathogens with different lifestyles
|Proceedings of the National Academy of Sciences|2007|735